RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade ; volume:15 ; number:1 ; day:30 ; month:8 ; year:2024 ; pages:1-18 ; date:12.2024
Nature Communications ; 15, Heft 1 (30.8.2024), 1-18, 12.2024
- Urheber
-
Nokin, Marie-Julie
Mira, Alessia
Patrucco, Enrico
Ricciuti, Biagio
Cousin, Sophie
Soubeyran, Isabelle
San José, Sonia
Peirone, Serena
Caizzi, Livia
Vietti Michelina, Sandra
Bourdon, Aurelien
Wang, Xinan
Alvarez-Villanueva, Daniel
Martínez-Iniesta, María
Vidal, August
Rodrigues, Telmo
García-Macías, Carmen
Awad, Mark M.
Nadal, Ernest
Villanueva, Alberto
Italiano, Antoine
Cereda, Matteo
Santamaría, David
Ambrogio, Chiara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-51828-2
- URN
-
urn:nbn:de:101:1-2411302107593.592611487880
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nokin, Marie-Julie
- Mira, Alessia
- Patrucco, Enrico
- Ricciuti, Biagio
- Cousin, Sophie
- Soubeyran, Isabelle
- San José, Sonia
- Peirone, Serena
- Caizzi, Livia
- Vietti Michelina, Sandra
- Bourdon, Aurelien
- Wang, Xinan
- Alvarez-Villanueva, Daniel
- Martínez-Iniesta, María
- Vidal, August
- Rodrigues, Telmo
- García-Macías, Carmen
- Awad, Mark M.
- Nadal, Ernest
- Villanueva, Alberto
- Italiano, Antoine
- Cereda, Matteo
- Santamaría, David
- Ambrogio, Chiara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
A β-Lactone for Covalent Inhibition of KRAS G12S
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
An in vivo inflammatory loop potentiates KRAS blockade
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Covalent Inhibition of Ras G12C with a Stapled Peptidomimetic
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS G12C
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
A β-Lactone for Covalent Inhibition of KRAS G12S
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
An in vivo inflammatory loop potentiates KRAS blockade
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Covalent Inhibition of Ras G12C with a Stapled Peptidomimetic
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS G12C
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
A β-Lactone for Covalent Inhibition of KRAS G12S
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
An in vivo inflammatory loop potentiates KRAS blockade
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Covalent Inhibition of Ras G12C with a Stapled Peptidomimetic